AZN
Astrazeneca Stock Analysis
AI Rating
- Quality7/10
- Growth↑ 7/10
- Value↓ 3/10
AZN Growth
- Revenue Y/Y↑ 8.63%
- EPS Y/Y↑ 45.37%
- FCF Y/Y↑ 17.87%
AZN Profitability
- Gross margin ↑ 81.90%
- EPS margin↑ 17.40%
- ROIC 5Y↑ 24.38%
AZN Dividends
- Dividend yield 4.55%
- Growth 3Y↑ 19.70%
- Payout ratio↑ 63%
AZN Risk
- Debt / Equity↓ 0.6
- Debt / FCF↓ 2.0
- Interest coverage↑ 8.3
Astrazeneca stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.